Talis Biomedical Corporation Revenue and Competitors
Estimated Revenue & Valuation
- Talis Biomedical Corporation's estimated annual revenue is currently $42.9M per year.
- Talis Biomedical Corporation's estimated revenue per employee is $320,410
- Talis Biomedical Corporation's total funding is $8.6M.
Employee Data
- Talis Biomedical Corporation has 134 Employees.
- Talis Biomedical Corporation grew their employee count by 0% last year.
Talis Biomedical Corporation's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO, Co-founder | Reveal Email/Phone |
2 | VP HR | Reveal Email/Phone |
3 | Controller | Reveal Email/Phone |
4 | VP, Assay Development | Reveal Email/Phone |
5 | VP, Produc | Reveal Email/Phone |
6 | R&D Director, Molecular Biology | Reveal Email/Phone |
7 | New Product Introduction Manager | Reveal Email/Phone |
8 | Research Associate | Reveal Email/Phone |
Talis Biomedical Corporation Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Talis Biomedical Corporation?
Talis is developing a new class of diagnostic platform to enable rapid, high-complexity testing across a wide range of healthcare settings. Our visionary team combines depth of experience with passion to deliver a pioneering solution to infectious disease diagnostics. Infectious disease treatment today is largely guideline-driven: treat patients with similar symptoms the same. Unfortunately, similar symptoms can often have very different causes. Our tests will enable caregivers to know within minutes, the cause of illness, as well as which medications will be effective for their patient, empowering them to provide individualized care rather than broad, guideline-dictated treatments. From the doctor's office to the hospital bedside to remote care settings, we are re-defining the treatment of infectious diseases.
keywords:Biotechnology,Healthcare
$8.6M
Total Funding
134
Number of Employees
$42.9M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Talis Biomedical Corporation News
Insiders who purchased Talis Biomedical Corporation (NASDAQ:TLIS) earlier this year lose an additional US$180k as the stock sinks to US$1.15.
Insiders who purchased Talis Biomedical Corporation (NASDAQ:TLIS) earlier this year lose an additional US$180k as the stock sinks to US$1.15.
MENLO PARK, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health...
MENLO PARK, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health...
MENLO PARK, Calif., Nov. 12, 2020 /PRNewswire/ -- Talis Biomedical Corporation, a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point of care, today announced it has strengthened its executive management team with the appointment of Rob Ke ...
Other Companies in Menlo Park
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15M | 136 | 6% | N/A |
#2 | $19.2M | 137 | -53% | $310.6M |
#3 | $21.5M | 139 | 15% | $189.5M |
#4 | $32.3M | 140 | 6% | N/A |
#5 | N/A | 142 | 190% | N/A |